# OXTELLAR XR

NDC: 17772-121
Generic name: OXCARBAZEPINE
Labeler / Manufacturer: Supernus Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20130117

FDA application: NDA202810

## Active ingredients

- OXCARBAZEPINE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"17772-121"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=17772-121
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa610e56-1d1d-11e1-8bc2-0800200c9a66